Literature DB >> 15870158

Effect of adiposity and fat distribution on endometrial cancer risk in Shanghai women.

Wang Hong Xu1, Charles E Matthews, Yong Bing Xiang, Wei Zheng, Zhi Xian Ruan, Jia Rong Cheng, Yu Tang Gao, Xiao Ou Shu.   

Abstract

The authors conducted a population-based case-control study of 832 endometrial cancer cases and 846 frequency-matched controls in Shanghai, China (1997-2001), to examine the association of overall adiposity and body fat distribution with disease risk. Overall adiposity was estimated using weight and body mass index (BMI); upper body fat distribution was evaluated using waist circumference and waist:hip ratio. Overall and upper-body obesity were both associated with an elevated risk of endometrial cancer. Adjusted odds ratios and 95% confidence intervals for highest-versus-lowest quartile comparisons were 2.6 (95% confidence interval (CI): 2.0, 3.5) for weight, 2.9 (95% CI: 2.2, 3.9) for BMI, 4.7 (95% CI: 3.4, 6.4) for waist circumference, and 3.5 (95% CI: 2.6, 4.8) for waist:hip ratio. The positive associations with weight and BMI vanished after results were controlled for waist circumference, while associations with waist circumference and waist:hip ratio persisted after adjustment for BMI. The positive association with upper-body obesity was more pronounced among younger women, women who had never used oral contraceptives, and women with a history of diabetes mellitus (p for multiplicative interaction < 0.05). Upper-body obesity was related to increased risk among women with low BMI. These results suggest that obesity, particularly upper-body fat deposition, is associated with an increased risk of endometrial cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15870158     DOI: 10.1093/aje/kwi127

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  25 in total

Review 1.  The metabolic syndrome: A high-risk state for cancer?

Authors:  Stephanie Cowey; Robert W Hardy
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

2.  Prospective study of body fat distribution and the risk of endometrial cancer.

Authors:  Woong Ju; Hyun Ja Kim; Susan E Hankinson; Immaculata De Vivo; Eunyoung Cho
Journal:  Cancer Epidemiol       Date:  2015-06-09       Impact factor: 2.984

Review 3.  Therapeutic effect of metformin in the treatment of endometrial cancer.

Authors:  Nan Mu; Tingting Xu; Mingxiao Gao; Mei Dong; Qing Tang; Li Hao; Guiqing Wang; Zenghui Li; Wenshuang Wang; Ying Yang; Jianqing Hou
Journal:  Oncol Lett       Date:  2020-08-24       Impact factor: 2.967

4.  Genetic polymorphisms in obesity-related genes and endometrial cancer risk.

Authors:  Xiaoli Chen; Yong-Bing Xiang; Ji-Rong Long; Hui Cai; Qiuyin Cai; Jiarong Cheng; Wanqing Wen; Yu-Tang Gao; Wei Zheng; Xiao-Ou Shu
Journal:  Cancer       Date:  2011-10-28       Impact factor: 6.860

5.  Spontaneous formation of tumorigenic hybrids between human omental adipose-derived stromal cells and endometrial cancer cells increased motility and heterogeneity of cancer cells.

Authors:  Mingxia Li; Xiaoping Li; Lijun Zhao; Jingyi Zhou; Yuan Cheng; Bo Xu; Jianliu Wang; Lihui Wei
Journal:  Cell Cycle       Date:  2019-01-22       Impact factor: 4.534

6.  Longitudinal evaluation of cancer-associated biomarkers before and after weight loss in RENEW study participants: implications for cancer risk reduction.

Authors:  Faina Linkov; G Larry Maxwell; Ashley S Felix; Yan Lin; Diana Lenzner; Dana H Bovbjerg; Anna Lokshin; Meredith Hennon; John M Jakicic; Bret H Goodpaster; James P DeLany
Journal:  Gynecol Oncol       Date:  2011-12-22       Impact factor: 5.482

7.  Association of dietary glycemic index and glycemic load with endometrial cancer risk among Chinese women.

Authors:  Wang Hong Xu; Yong-Bing Xiang; Xianglan Zhang; Zhixian Ruan; Hui Cai; Wei Zheng; Xiao-Ou Shu
Journal:  Nutr Cancer       Date:  2014-12-12       Impact factor: 2.900

8.  The modifying effect of C-reactive protein gene polymorphisms on the association between central obesity and endometrial cancer risk.

Authors:  Wanqing Wen; Qiuyin Cai; Yong-Bing Xiang; Wang-Hong Xu; Zhi Xian Ruan; Jiarong Cheng; Wei Zheng; Xiao-Ou Shu
Journal:  Cancer       Date:  2008-06       Impact factor: 6.860

9.  YAP/TAZ regulates the insulin signaling via IRS1/2 in endometrial cancer.

Authors:  Chao Wang; Kangjin Jeong; Hongyuan Jiang; Wei Guo; Chao Gu; Yiling Lu; Jiyong Liang
Journal:  Am J Cancer Res       Date:  2016-05-01       Impact factor: 6.166

Review 10.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.